184 related articles for article (PubMed ID: 35524221)
1. Visual and digital assessment of Ki-67 in breast cancer tissue - a comparison of methods.
Skjervold AH; Pettersen HS; Valla M; Opdahl S; Bofin AM
Diagn Pathol; 2022 May; 17(1):45. PubMed ID: 35524221
[TBL] [Abstract][Full Text] [Related]
2. A Comparison of Visual Assessment and Automated Digital Image Analysis of Ki67 Labeling Index in Breast Cancer.
Zhong F; Bi R; Yu B; Yang F; Yang W; Shui R
PLoS One; 2016; 11(2):e0150505. PubMed ID: 26928407
[TBL] [Abstract][Full Text] [Related]
3. A methodology to ensure and improve accuracy of Ki67 labelling index estimation by automated digital image analysis in breast cancer tissue.
Laurinavicius A; Plancoulaine B; Laurinaviciene A; Herlin P; Meskauskas R; Baltrusaityte I; Besusparis J; Dasevicius D; Elie N; Iqbal Y; Bor C
Breast Cancer Res; 2014; 16(2):R35. PubMed ID: 24708745
[TBL] [Abstract][Full Text] [Related]
4. Digital image analysis of Ki67 proliferation index in breast cancer using virtual dual staining on whole tissue sections: clinical validation and inter-platform agreement.
Koopman T; Buikema HJ; Hollema H; de Bock GH; van der Vegt B
Breast Cancer Res Treat; 2018 May; 169(1):33-42. PubMed ID: 29349710
[TBL] [Abstract][Full Text] [Related]
5. Invasive lobular carcinoma of the breast: assessment of proliferative activity using automated Ki-67 immunostaining.
Dessauvagie B; Thomas A; Thomas C; Robinson C; Combrink M; Budhavaram V; Kunjuraman B; Meehan K; Sterrett G; Harvey J
Pathology; 2019 Dec; 51(7):681-687. PubMed ID: 31630876
[TBL] [Abstract][Full Text] [Related]
6. Practical issues concerning the implementation of Ki-67 proliferative index measurement in breast cancer reporting.
Harvey J; Thomas C; Wood B; Hardie M; Dessauvagie B; Combrinck M; Frost FA; Sterrett G
Pathology; 2015 Jan; 47(1):13-20. PubMed ID: 25474507
[TBL] [Abstract][Full Text] [Related]
7. Digital immunohistochemistry wizard: image analysis-assisted stereology tool to produce reference data set for calibration and quality control.
Plancoulaine B; Laurinaviciene A; Meskauskas R; Baltrusaityte I; Besusparis J; Herlin P; Laurinavicius A
Diagn Pathol; 2014; 9 Suppl 1(Suppl 1):S8. PubMed ID: 25565221
[TBL] [Abstract][Full Text] [Related]
8. Validity and reliability of Ki-67 assessment in oestrogen receptor positive breast cancer.
Jing N; Fang C; Williams DS
Pathology; 2017 Jun; 49(4):371-378. PubMed ID: 28450087
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of digital and visual methods for Ki-67 assessment in invasive breast carcinomas].
Kushnarev VA; Artemyeva ES; Kudaybergenova AG
Arkh Patol; 2018; 80(2):38-42. PubMed ID: 29697670
[TBL] [Abstract][Full Text] [Related]
10. Automated assessment of Ki-67 in breast cancer: the utility of digital image analysis using virtual triple staining and whole slide imaging.
Hida AI; Omanovic D; Pedersen L; Oshiro Y; Ogura T; Nomura T; Kurebayashi J; Kanomata N; Moriya T
Histopathology; 2020 Sep; 77(3):471-480. PubMed ID: 32578891
[TBL] [Abstract][Full Text] [Related]
11. Ki-67 Proliferation Index Assessment in Gastroenteropancreatic Neuroendocrine Tumors by Digital Image Analysis With Stringent Case and Hotspot Level Concordance Requirements.
Boukhar SA; Gosse MD; Bellizzi AM; Rajan K D A
Am J Clin Pathol; 2021 Sep; 156(4):607-619. PubMed ID: 33847759
[TBL] [Abstract][Full Text] [Related]
12. Comparison of visual assessment and image analysis in the evaluation of Ki-67 expression and their prognostic significance in immunohistochemically defined luminal breast carcinoma.
Arihiro K; Oda M; Ohara M; Kadoya T; Osaki A; Nishisaka T; Shiroma N; Kobayashi Y
Jpn J Clin Oncol; 2016 Dec; 46(12):1081-1087. PubMed ID: 27511992
[TBL] [Abstract][Full Text] [Related]
13. Standardization for Ki-67 assessment in moderately differentiated breast cancer. A retrospective analysis of the SAKK 28/12 study.
Varga Z; Cassoly E; Li Q; Oehlschlegel C; Tapia C; Lehr HA; Klingbiel D; Thürlimann B; Ruhstaller T
PLoS One; 2015; 10(4):e0123435. PubMed ID: 25885288
[TBL] [Abstract][Full Text] [Related]
14. Potential Pitfalls in Diagnostic Digital Image Analysis: Experience with Ki-67 and PHH3 in Gastrointestinal Neuroendocrine Tumors.
Hacking SM; Sajjan S; Lee L; Ziemba Y; Angert M; Yang Y; Jin C; Chavarria H; Kataria N; Jain S; Nasim M
Pathol Res Pract; 2020 Mar; 216(3):152753. PubMed ID: 31761497
[TBL] [Abstract][Full Text] [Related]
15. Reliability and Variability of Ki-67 Digital Image Analysis Methods for Clinical Diagnostics in Breast Cancer.
Dawe M; Shi W; Liu TY; Lajkosz K; Shibahara Y; Gopal NEK; Geread R; Mirjahanmardi S; Wei CX; Butt S; Abdalla M; Manolescu S; Liang SB; Chadwick D; Roehrl MHA; McKee TD; Adeoye A; McCready D; Khademi A; Liu FF; Fyles A; Done SJ
Lab Invest; 2024 May; 104(5):100341. PubMed ID: 38280634
[TBL] [Abstract][Full Text] [Related]
16. Reproducibility and Prognostic Potential of Ki-67 Proliferation Index when Comparing Digital-Image Analysis with Standard Semi-Quantitative Evaluation in Breast Cancer.
Ács B; Madaras L; Kovács KA; Micsik T; Tőkés AM; Győrffy B; Kulka J; Szász AM
Pathol Oncol Res; 2018 Jan; 24(1):115-127. PubMed ID: 28401450
[TBL] [Abstract][Full Text] [Related]
17. Digital quantification of KI-67 in breast cancer.
Del Rosario Taco Sanchez M; Soler-Monsó T; Petit A; Azcarate J; Lasheras A; Artal C; Gil M; Falo C; Pla MJ; Matias-Guiu X
Virchows Arch; 2019 Feb; 474(2):169-176. PubMed ID: 30465110
[TBL] [Abstract][Full Text] [Related]
18. Proliferation assessment in breast carcinomas using digital image analysis based on virtual Ki67/cytokeratin double staining.
Røge R; Riber-Hansen R; Nielsen S; Vyberg M
Breast Cancer Res Treat; 2016 Jul; 158(1):11-19. PubMed ID: 27283833
[TBL] [Abstract][Full Text] [Related]
19. The human-in-the-loop: an evaluation of pathologists' interaction with artificial intelligence in clinical practice.
Bodén ACS; Molin J; Garvin S; West RA; Lundström C; Treanor D
Histopathology; 2021 Aug; 79(2):210-218. PubMed ID: 33590577
[TBL] [Abstract][Full Text] [Related]
20. Sequential immunohistochemistry and virtual image reconstruction using a single slide for quantitative KI67 measurement in breast cancer.
Serna G; Simonetti S; Fasani R; Pagliuca F; Guardia X; Gallego P; Jimenez J; Peg V; Saura C; Eppenberger-Castori S; Ramon Y Cajal S; Terracciano L; Nuciforo P
Breast; 2020 Oct; 53():102-110. PubMed ID: 32707454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]